Analyst Ratings February 24, 2026

Needham Trims EverQuote Price Target After Softer Q1 Guidance; Buy Rating Stands

Broker lowers target to $25 from $40 even as EverQuote delivers record Q4 results and reiterates billion-dollar revenue goal

By Jordan Park EVER
Needham Trims EverQuote Price Target After Softer Q1 Guidance; Buy Rating Stands
EVER

Needham reduced its price target on EverQuote (EVER) to $25 from $40 while keeping a Buy rating after the insurtech reported record fourth-quarter results and provided first-quarter guidance below consensus. The company posted strong Q4 metrics driven by increased carrier spending, reiterated a plan to reach $1 billion in revenue within two to three years, and forecast margin and EBITDA dollar expansion in fiscal 2026. Other firms also adjusted targets following the softer near-term outlook despite upside in quarterly performance.

Key Points

  • Needham lowered its price target on EverQuote to $25 from $40, while maintaining a Buy rating.
  • EverQuote posted record Q4 results with 32.5% year-over-year revenue growth and trailing twelve-month revenue of $644.66 million; shares trade at $15.32, down 43% YTD and below a 52-week high of $30.03.
  • Management reiterated a path to $1 billion in revenue within two to three years and expects roughly 100 basis points of EBITDA margin expansion and at least 20% EBITDA dollar growth in fiscal 2026.

Needham has lowered its price target on EverQuote (NASDAQ:EVER) to $25 from $40 but left its Buy rating intact after the company released fourth-quarter results and first-quarter guidance that came in under consensus.

EverQuote reported a record fourth quarter characterized by a 32.5% year-over-year increase in revenue, reflecting higher spending from insurance carriers amid a profitable industry backdrop. The company’s trailing twelve-month revenue sits at $644.66 million. Despite those gains, EverQuote shares trade at $15.32, representing a 43% decline year-to-date and remaining well below a 52-week high of $30.03.

Management offered first-quarter guidance that was below market expectations, attributing the moderation to carriers adopting a more disciplined approach to spending after the robust fourth quarter. Management reiterated the company’s longer-term target of achieving $1 billion in revenue within the next two to three years. In addition, company guidance calls for EBITDA margin expansion of roughly 100 basis points in fiscal 2026 alongside at least 20% growth in EBITDA dollars.

Analyst commentary included a note from Needham that, while lowering the price target, emphasized potential upside tied to favorable carrier profitability and an expanding product suite. Needham maintained its Buy rating based on the view that those factors could lift results as the year progresses.

Separate analyses referenced by market research tools suggest the stock appears undervalued at current levels, and analysts expect continued sales growth. Those tools also offer a detailed Pro Research Report that consolidates the company’s financial metrics and outlook for investors evaluating the investment case.

Additional broker moves followed the company’s quarterly release. EverQuote’s fourth-quarter 2025 earnings greatly outpaced expectations, posting earnings per share of $1.54 versus a forecast of $0.36, and generating revenue of $195.3 million compared with a $176.82 million estimate. These results translated to a 327.78% EPS surprise and a 10.45% revenue surprise.

In the wake of the results and the conservative near-term guidance, Canaccord Genuity trimmed its price target on EverQuote to $28 from $33 while keeping a Buy rating. The firm cited the company’s below-expectations first-quarter guidance as the reason for the adjustment. EverQuote also reported that its top four carriers by spend remained unchanged from the third quarter, and the company achieved a 12% sequential revenue increase, setting a fourth-quarter record.

The juxtaposition of a standout fourth quarter and cautious near-term guidance has prompted some price-target reductions even as analysts leave ratings unchanged, leaving investors to weigh strong recent execution against more conservative short-term carrier spending assumptions.


Summary

Needham cut its EverQuote price target to $25 from $40 but upheld a Buy rating after the company delivered record fourth-quarter results and issued first-quarter guidance below consensus. EverQuote reaffirmed a plan to reach $1 billion in revenue within two to three years and outlined expectations for margin and EBITDA dollar growth in fiscal 2026.

Risks

  • Short-term carrier spending discipline: First-quarter guidance came in below consensus as carriers reduced spending following strong Q4 levels, creating near-term revenue risk for EverQuote - impacts advertising and insurtech markets.
  • Analyst target adjustments: Despite strong quarterly execution, firms such as Needham and Canaccord Genuity lowered price targets, reflecting uncertainty in guidance and near-term visibility - impacts equity valuations in the internet/marketing technology sector.
  • Valuation and market reaction: The stock trades well below its 52-week high and remains down significantly year-to-date, indicating investor sensitivity to guidance and execution timing - impacts investor sentiment in tech and insurance-adjacent stocks.

More from Analyst Ratings

Wolfe Research Starts Coverage of Centessa, Assigns Outperform and $40 Target Feb 24, 2026 Wolfe Research Starts Coverage on Praxis Precision with Outperform Call and $500 Target Feb 24, 2026 RBC Reaffirms Outperform on Neurocrine, Sees Buyout Interest as Revenue Grows Feb 24, 2026 Morgan Stanley Trims JBS Price Target but Keeps Overweight Call as Quarter Looks Resilient Feb 24, 2026 Piper Sandler Lowers Beyond Inc Price Target, Cites Integration Uncertainty Feb 24, 2026